Andrew L Gordon

Administrative Lead for the Heart and Vascular, Orthopedic, and Neuroscience Service Line. Led the strategic growth of H&V program which included introduction of a Structural Heart, Advanced Cardiac Surgery, and Advanced EP program in just over 3 years.

• Successfully launched TAVR program during COVID-19 pandemic under aggressive timeline.
• EP procedural volume has grown over 30% in 5 fiscal years (including COVID-19 impact). Championed the establishment of a unique AFib Center model that increased ablation volume by 10% in the first year.
• Over 30% growth in total hip and knee surgeries over 5 fiscal years.
• Launched Penn Pain Management program in local market which grew 33% in its 3rd year.
• Developed and launched Same Day Discharge program for Orthopedic Total Joints.

Led the strategic planning and marketing of the Heart and Vascular Service Line including sub-specialty programs at 4 hospital entities, and multiple community cardiology practices. Led the strategic planning and marketing of the Women's Health Service Line.

• Active leadership role in transforming the Marketing Department into a strategic center and changing the organizational mindset.
• Established digital marketing presence for both Heart and Vascular and Women's Health Service Lines - launched over 5 separate sub-specialty focused digital campaigns.
• Penn Medicine Corporate Lead (2017) for the American Heart Association Heart Walk in which we were the top fund raising organization in the SE PA region and top 10 in the country.

Led a 33 member Global Business Insight function through a transitional rebuild. Direct management of 8 member leadership team with responsibilities for forecasting, data management, primary and secondary research, and insight input into product strategy.

• Recruited and hired 18 people in 4 months while ensuring delivery against key objectives.

Led an international cross functional team to provide commercial strategic direction and global marketing activities for a multi-billion dollar cardiovascular product.

• Achieved double digit sales growth on CRESTOR(TM) in the ninth year post launch.
• Represented the Global Marketing Function in the development of a Compliance Program which was implemented across the entire Global Commercial Organization.

Responsible for program strategic planning, stakeholder management, resourcing, and oversight in the US and in Canada. The Program included 10 projects impacting key international markets.

• Co-Leader of a global project team awarded the CEOs Award in 2009 for development and implementation of core commercial capabilities (eLearning, Multi-channel marketing, low cost sourcing).
• The project team became the foundation for new Commercial Excellence function in Global Marketing.

Responsible for two respiratory brands totaling over $350M annual sales. Member of the Respiratory Senior Leadership Team.

• Assumed leadership of the team during the launch of a key asthma brand and successfully directed the transition of the brands between operational units.
• Co-led (with Medimmune counterpart) the first product integration/shared selling agreement between AstraZeneca and Medimmune resulting in a successful, on time launch under extremely aggressive timelines.

Lead a 90 member sales team including 8 District Sales Managers through the creation of a Respiratory SalesTeam, a sales force reorganization, the implementation of a new selling model, and sales technology platform upgrade.

• Along with RSD regional counterpart, designed and gained leadership approval to implement a interim field structure that addressed several vacancy issues as well as positioned the team for a new selling model.

Led a team of marketing professionals responsible for all aspects of Healthcare Professional marketing for a pediatric asthma product. Served on the brand leadership team responsible for setting strategic direction and delivering financial results to the organization.

• Achieved >20% growth in sales and greater percent increase in contribution during the first year as Brand Director.
• Assisted in the business case development for additional manufacturing lines which resulted in a positive decision.
• Championed the business case for a dedicated sales team supporting respiratory products which resulted in the establishment of a new pediatric sales force.